TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Reviva Bio AB
Closing information (x1000 SEK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
38,773
|
18,405
|
11,776 |
| Financial expenses |
112
|
6
|
0 |
| Earnings before taxes |
7,806
|
1,450
|
1,184 |
| EBITDA |
8,725
|
1,551
|
1,267 |
| Total assets |
23,047
|
13,039
|
6,822 |
| Current assets |
15,911
|
12,708
|
6,547 |
| Current liabilities |
6,698
|
6,486
|
1,445 |
| Equity capital |
11,961
|
5,812
|
4,676 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
19
|
11
|
8 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
51.9%
|
44.6%
|
68.5% |
| Turnover per employee |
2,041
|
1,673
|
1,472 |
| Profit as a percentage of turnover |
20.1%
|
7.9%
|
10.1% |
| Return on assets (ROA) |
34.4%
|
11.2%
|
17.4% |
| Current ratio |
237.5%
|
195.9%
|
453.1% |
| Return on equity (ROE) |
65.3%
|
24.9%
|
25.3% |
| Change turnover |
20,368
|
6,629
|
1,359 |
| Change turnover % |
111%
|
56%
|
13% |
| Chg. No. of employees |
8
|
3
|
0 |
| Chg. No. of employees % |
73%
|
38%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.